Clinical Trial Update: Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin in newly diagnosed acute promyelocytic leukemia (PML-RAR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)
• Trisenox (arsenic trioxide)
• Vesanoid (all-trans retinoic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Promyelocytic Leukemia With PML-RARA | Phase 2 | Status: RECRUITING